Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: A pooled analysis of two randomised trials

The Lancet Oncology

Volumn 16, Issue 6, 2015, Pages 630-637

  Chang, Joe Y ^a   Senan, Suresh ^b   Paul, Marinus A ^b   Mehran, Reza J ^a   Louie, Alexander V ^b   Balter, Peter ^a   Groen, Harry J M ^c   McRae, Stephen E ^a   Widder, Joachim ^c   Feng, Lei ^a   van den Borne, Ben E E M ^d   Munsell, Mark F ^a   Hurkmans, Coen ^d   Berry, Donald A ^a   van Werkhoven, Erik ^e   Kresl, John J ^f   Dingemans, Anne Marie ^g   Dawood, Omar ^h   Haasbeek, Cornelis J A ^b   Carpenter, Larry S ⁱ   De Jaeger, Katrien ^d   Komaki, Ritsuko ^a   Slotman, Ben J ^b   Smit, Egbert F ^b   Roth, Jack A ^a   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d CATHARINA HOSPITAL   (Netherlands)

^e NETHERLANDS CANCER INSTITUTE   (Netherlands)

^f Phoenix CyberKnife and Radiation Oncology Center   (United States)

^g MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^h Kona Medical   (United States)

ⁱ St Lukes Episcopal Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; ADULT; ADVERSE OUTCOME; AGED; ANEMIA; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COUGHING; DISTANT METASTASIS; DYSPNEA; FATIGUE; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HERNIA; HUMAN; INTERMETHOD COMPARISON; LOBECTOMY; LUNG INFECTION; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PALLIATIVE THERAPY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE FREE SURVIVAL; RIB FRACTURE; STEREOTACTIC ABLATIVE RADIOTHERAPY; STEREOTACTIC TREATMENT; THORAX PAIN; TREATMENT FAILURE; WEDGE RESECTION; WEIGHT REDUCTION; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIAL; LYMPH NODE; MIDDLE AGED; NETHERLANDS; PATHOLOGY; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; RADIOSURGERY; TEMPORAL LOBECTOMY; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTERIOR TEMPORAL LOBECTOMY; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NETHERLANDS; RADIOSURGERY; TREATMENT OUTCOME;

EID: 84930272308     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(15)70168-3     Document Type: Article

References (25)

1. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004, 101:1623-1631.
2. Lagerwaard FJ, Haasbeek CJ, Smit EF, Slotman BJ, Senan S Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008, 70:685-692.
3. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010, 303:1070-1076.
4. Chang JY, Liu H, Balter P, et al. Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer. Radiat Oncol 2012, 10:152.
5. Taremi M, Hope A, Dahele M, et al. Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients. Int J Radiat Oncol Biol Phys 2012, 82:967-973.
6. Onishi H, Shirato H, Nagata Y, et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?. Int J Radiat Oncol Biol Phys 2011, 81:1352-1358.
7. Nagata Y, Hiraoka M, Shibata T, et al. A phase II trial of stereotactic body radiation therapy for operable TIN0M0 non-small cell lung cancer: Japan Clinical Oncology Group (JCOG0403). Int J Radiat Oncol Biol Phys 2010, 78:S27. (abstr).
8. Timmerman RD, Paulus R, Pass HI, et al. RTOG 0618: Stereotactic body radiation therapy (SBRT) to treat operable early-stage lung cancer patients. Proc Am Soc Clin Oncol 2013, 31(suppl):S7523. (abstr).
9. Lagerwaard FJ, Verstegen NE, Haasbeek CJ, et al. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 2012, 83:348-353.
10. Crabtree TD, Denlinger CE, Meyers BF, et al. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2010, 140:377-386.
11. Verstegen NE, Oosterhuis JW, Palma DA, et al. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. Ann Oncol 2013, 24:1543-1548.
12. Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman BJ, Senan S Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. J Clin Oncol 2010, 28:5153-5159.
13. Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman B, Senan S Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery. Radiother Oncol 2011, 101:240-244.
14. Shirvani SM, Jiang J, Chang JY, et al. Lobectomy, sublobar resection, and stereotactic radiation for stage 1 non-small cell lung cancers in the elderly. JAMA Surg 2014, 149:1244-1253.
15. Verstegen NE, Lagerwaard FJ, Senan S Developments in early-stage NSCLC: advances in radiotherapy. Ann Oncol 2012, 23:46-51.
16. Zhang X, Liu H, Balter P, et al. Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2012, 83:1558-1565.
17. Whitson BA, Groth SS, Duval SJ, Swanson SJ, Maddaus MA Surgery for early-stage non-small cell lung cancer: a systematic review of the video-assisted thoracoscopic surgery versus thoracotomy approaches to lobectomy. Ann Thorac Surg 2008, 86:2008-2016.
18. Paul S, Sedrakyan A, Chiu YL, et al. Outcomes after lobectomy using thoracoscopy vs thoracotomy: a comparative effectiveness analysis utilizing the Nationwide Inpatient Sample database. Eur J Cardiothorac Surg 2012, 43:813-817.
19. Boffa DJ, Allen MS, Grab JD, Gaissert HA, Harpole DH, Wright CD Data from The Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors. J Thorac Cardiovasc Surg 2008, 135:247-254.
20. Allen MS, Darling GE, Pechet TT, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 2006, 81:1013-1019.
21. Pezzi CM, Mallin K, Mendez AS, et al. Ninety-day mortality after resection for lung cancer is nearly double 30-day mortality. J Thorac Cardiovasc Surg 2014, 148:2269-2278.
22. Grutters JP, Kessels AG, Pijls-Johannesma M, De Ruysscher D, Joore MA, Lambin P Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. Radiother Oncol 2010, 95:32-40.
23. Lou F, Huang J, Sima CS, Dycoco J, Rusch V, Bach PB Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance. J Thorac Cardiovasc Surg 2013, 145:75-81.
24. Ginsberg R, Rubinstein L Randomized trial of lobectomy versus limited resection for T1 N0 nonsmall cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995, 60:615-622.
25. Tournoy KG, Keller SM, Annema JT Mediastinal staging of lung cancer: novel concepts. Lancet Oncol 2012, 13:e221-e229.